China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Evaluation of Lecanemab Efficacy Based on Functional and Structural Brain Gradients in Patients with Alzheimer’s Disease'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130620
Registration Time: 2026/08/21
Type: Observational study
Primary Sponsor: Zhejiang Provincial People's Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339398
Published by HT Digital Content Services with permission from Health Daily Digest....